Skip to main content

Broadwood Partners, L.P.'s Form 4 filing

Insight Molecular Diagnostics Inc. (IMDX) · filed Apr 15, 2022

Accession no.
0000919574-22-002783
Filed
Apr 15, 2022, 6:13 PM ET
Trade date
Apr 13-14, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 4 derivative transactions. Open-market purchases total $8.00M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Broadwood Partners, L.P.CIK 000127838610% Owner
Broadwood Capital IncCIK 000127838710% Owner
Bradsher Neal CCIK 000127838810% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 14, 2022Common Stock, no par valuePPurchaseAcquired+6,003,752$1.33+$7,999,999.5423,353,697Direct
Apr 14, 2022Common Stock, no par valuePPurchaseAcquired0$0.00$023,353,697Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 13, 2022Common StockAGrant or awardAcquired+3,884,675––5,882.35Direct
Apr 13, 2022Common StockAGrant or awardAcquired+3,884,675––5,882.35Indirect
Apr 14, 2022Common StockAGrant or awardAcquired+3,001,876––6,003,752Direct
Apr 14, 2022Common StockAGrant or awardAcquired+3,001,876––6,003,752Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)